In last trading session, Rapid Micro Biosystems Inc (NASDAQ:RPID) saw 0.5 million shares changing hands with its beta currently measuring 1.32. Company’s recent per share price level of $3.21 trading at -$0.45 or -12.30% at ring of the bell on the day assigns it a market valuation of $138.14M. That closing price of RPID’s stock is at a discount of -25.86% from its 52-week high price of $4.04 and is indicating a premium of 81.93% from its 52-week low price of $0.58.

For Rapid Micro Biosystems Inc (RPID), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.22 in the current quarter.

Rapid Micro Biosystems Inc (NASDAQ:RPID) trade information

Upright in the red during last session for losing -12.30%, in the last five days RPID remained trading in the red while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $3.21 price level, adding 20.54% to its value on the day. Rapid Micro Biosystems Inc’s shares saw a change of 256.67% in year-to-date performance and have moved -10.08% in past 5-day. Rapid Micro Biosystems Inc (NASDAQ:RPID) showed a performance of 127.66% in past 30-days.

Wall Street analysts have assigned a consensus price target of 8 to the stock, which implies a rise of 59.88% to its current value. Analysts have been projecting 8 as a low price target for the stock while placing it at a high target of 8. It follows that stock’s current price would drop -149.22% in reaching the projected high whereas dropping to the targeted low would mean a loss of -149.22% for stock’s current value.

Rapid Micro Biosystems Inc (RPID) estimates and forecasts

This year revenue growth is estimated to rise 24.78% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 8.2M for the same. And 2 analysts are in estimates of company making revenue of 6.6M in the next quarter. Company posted 6.34M and 5.61M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -16.10% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 11.20% while estimates for its earnings growth in next 5 years are of 12.40%.

Rapid Micro Biosystems Inc (NASDAQ:RPID)’s Major holders

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC is the top institutional holder at RPID for having 8.43 million shares of worth $5.57 million. And as of 2024-06-30, it was holding 19.5038 of the company’s outstanding shares.

The second largest institutional holder is KENNEDY LEWIS MANAGEMENT LP, which was holding about 4.94 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.4229 of outstanding shares, having a total worth of $3.26 million.

On the other hand, Vanguard Total Stock Market Index Fund and BlackRock Health Sciences Term Trust are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 594.57 shares of worth $1.91 million or 1.58% of the total outstanding shares. The later fund manager was in possession of 571.18 shares on Sep 30, 2024 , making its stake of worth around $1.83 million in the company or a holder of 1.51% of company’s stock.